Medicine guide
Zerit
·
- Prescription status not stated
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Stavudine
- Made by
- Bristol-Myers Squibb Pharma EEIG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Hard capsules Zerit is indicated in combination with other antiretroviral medicinal products for the treatment of HIV-infected adult patients and paediatric patients (over the age of three months) only when other antiretrovirals can not be used. The duration of therapy with Zerit should be limited to the shortest time possible. Powder for oral solution Zerit is indicated in combination with other antiretroviral medicinal products for the treatment of HIV-infected adult patients and paediatric patients (from birth) only when other antiretrovirals can not be used. The duration of therapy with Zerit should be limited to the shortest time possible.
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | Bristol-Myers Squibb Pharma EEIG |
|---|---|
| Active substance | Stavudine |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Classification | J05AF04 · Antibiotics, antivirals and antifungals taken into the body |
| Authorised on | 1996-05-08 |
| Last updated by the regulator | 2020-10-13 |
| EMA product number | EMEA/H/C/000110 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).